VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ABLAbacus Global Management, Inc.
$8.09$791M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksABLQuarterly Financials

Abacus Global Management, Inc. (ABL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Abacus Global Management, Inc. (ABL) quarterly income statement — complete revenue, gross profit & net income history

ABL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23
Revenue-163.34M62.98M56.22M44.14M33.21M28.15M29.08M21.49M23.7M21.12M11.38M10.27M
Revenue Growth %-591.81%123.72%93.37%105.42%40.16%33.27%155.53%109.15%617.3%83.54%99.91%4.01%
Medical Costs & Claims20.82M7.66M6.05M7.11M3.72M2.19M2.74M2.72M1.66M3.36M973.4K489.55K
Medical Cost Ratio %-12.75%12.16%10.77%16.1%11.2%7.77%9.44%12.66%7.02%15.93%8.55%4.77%
Gross Profit-142.52M55.32M50.17M37.03M29.49M25.96M26.33M18.77M22.03M17.76M10.41M9.78M
Gross Margin %87.25%87.84%89.23%83.9%88.8%92.23%90.56%87.34%92.98%84.07%91.45%95.23%
Gross Profit Growth %-583.24%113.09%90.52%97.33%33.86%46.21%153.07%91.81%227.35%82.06%390.82%15.68%
Operating Expenses36.8M32.91M27.65M16M46.25M19.11M19.56M16.51M20.04M11.46M2.03M2.26M
OpEx / Revenue %-22.53%52.25%49.18%36.26%139.27%67.89%67.28%76.85%84.57%54.24%17.88%21.95%
Depreciation & Amortization4.26M4.4M5.18M4.76M2.73M1.75M1.75M1.68M1.71M1.69M1.1K1.04K
Combined Ratio %-35.28%64.41%59.95%52.36%150.47%75.66%76.71%89.51%91.59%70.17%26.44%26.72%
Operating Income22.8M22.41M22.52M21.03M-16.76M6.85M6.77M2.25M1.99M6.3M8.37M7.53M
Operating Margin %-13.96%35.59%40.05%47.64%-50.47%24.34%23.29%10.49%8.41%29.83%73.56%73.28%
Operating Income Growth %236.01%227.2%232.6%833.23%-940.73%8.73%-19.11%-70.07%108.6%-40.93%9286.85%5.63%
EBITDA27.06M26.81M27.7M25.79M-14.03M8.6M8.52M3.94M3.71M7.99M8.37M7.53M
EBITDA Margin %-16.57%42.58%49.27%58.42%-42.24%30.54%29.31%18.31%15.64%37.85%73.57%73.29%
Interest Expense-10.68M9.74M8.75M9.62M5.86M4.22M4.53M3.67M6.25M2.68M584.08K357.38K
Non-Operating Income0906.67K-7.91M3.68M-6.42M8.17M-167.88K-1.32M2.88M859.49K-121.6K202.97K
Pretax Income11.56M11.77M21.68M7.73M-16.21M-5.54M2.41M-101.96K-7.13M2.76M7.91M6.97M
Pretax Margin %-7.08%18.69%38.56%17.52%-48.79%-19.66%8.29%-0.47%-30.11%13.07%69.5%67.83%
Income Tax4.34M4.69M4.07M2.33M2.8M-250.37K1.76M1.17M-769.88K1.71M1.18M-656.47K
Effective Tax Rate %37.51%39.88%18.77%30.18%-17.3%4.52%72.95%-1150.98%10.79%61.94%14.98%-9.42%
Net Income7.23M7.08M17.58M4.64M-18.26M-5.13M769.98K-1.35M-6.22M903.36K6.75M8.09M
Net Margin %-4.42%11.24%31.27%10.51%-54.97%-18.21%2.65%-6.28%-26.26%4.28%59.32%78.7%
Net Income Growth %139.58%238.05%2183.65%443.99%-193.41%-667.33%-88.59%-116.68%71.14%-90.96%7579.97%15.3%
EPS (Diluted)0.080.070.180.05-0.22-0.070.01-0.02-0.100.01-0.01-0.01
EPS Growth %134.09%206.71%1465.22%322.43%-120%-579.72%--105.77%-97.63%111%80.69%-104.73%
EPS (Basic)0.080.070.190.05-0.22-0.070.01-0.02-0.100.01-0.01-0.01
Diluted Shares Outstanding96.65M96.65M97.37M97.5M81.78M74.69M67.16M63.03M60.4M63.35M63.35M63.35M